Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;90(1):50-57.

Perioperative Management of Patients on Maintenance Medication for Addiction Treatment: The Development of an Institutional Guideline

Gillian A Beauchamp  1 , Jill L Hanisak  2 , Alexandra M Amaducci  3 , Andrew L Koons  4 , Jason Laskosky  5 , Bernadette M Maron  6 , Thomas M McLoughlin  7
Affiliations
  • PMID: 35076384

Perioperative Management of Patients on Maintenance Medication for Addiction Treatment: The Development of an Institutional Guideline

Gillian A Beauchamp et al. AANA J. 2022 Feb.

Abstract

With a brief summary of selected literature identified by a multidisciplinary panel of subject matter experts, the authors share their experience with the development of an institutional perioperative pain management guideline for patients on maintenance medication for addiction treatment (MAT), stressing the importance of perioperative continuation of opioid agonists such as methadone and partial agonists such as buprenorphine; and the discontinuation of opioid antagonists, such as naltrexone. The authors' protocol is appended as an example of a standardized approach to perioperative management of patients on MAT.

Keywords: Anesthesiology; medication for addiction treatment; pain management; perioperative management; substance use disorder.

PubMed Disclaimer

Conflict of interest statement

Name: Gillian A. Beauchamp, MD Contribution: This author made significant contributions to the conception, synthesis, writing and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None Name: Jill L. Hanisak, DNP, CRNA Contribution: This author made significant contributions to the conception, synthesis, writing and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None Name: Alexandra M. Amaducci, DO Contribution: This author made significant contributions to the conception, synthesis, writing and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None Name: Andrew L. Koons, DO Contribution: This author made significant contributions to the conception, synthesis, writing and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None Name: Jason Laskosky, Pharm D, BCPS Contribution: This author made significant contributions to the conception, synthesis, writing and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None Name: Bernadette M. Maron, RN, BHCM Contribution: This author made significant contributions to the conception, synthesis, writing and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None Name: Thomas M. McLoughlin, Jr, MD Contribution: This author made significant contributions to the conception, synthesis, writing and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None The authors did discuss off-label use within the article. Disclosure statements are available for viewing upon request.

MeSH terms

LinkOut - more resources